Skip to main content
Fig. 2 | BMC Ophthalmology

Fig. 2

From: The role of vasoactive intestinal peptide (VIP) in atropine-related inhibition of the progression of myopia

Fig. 2

Changes in the refractive power (A) and axial length (B) in the right eyes of the different groups (mean ± SD). Compared with the control group at the same time point,*P < 0.05, **P < 0.01, ***P < 0.001. Compared with the FDM group at the same time point,#P < 0.05, ##P < 0.01, ###P < 0.001

Back to article page